Actively Recruiting
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
Led by University of Rochester · Updated on 2026-03-30
120
Participants Needed
1
Research Sites
128 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a two-arm pilot randomized trial that assesses the feasibility and preliminary efficacy of a digital story and values clarification intervention (Considering alloHCT: Opportunities for Patient Reflection During Decision-Making via Digital Stories \[CHORDS\]) compared to usual care among patients with myeloid cancers considering allogeneic hematopoietic cell transplantation (alloHCT).
CONDITIONS
Official Title
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 21 years old
- Diagnosis of myeloid cancer (AML, MDS, myelofibrosis, CML, or MDS/MPN)
- Being considered for allogeneic hematopoietic cell transplantation (alloHCT)
- Able to provide informed consent
- Able to speak English
You will not qualify if you...
- Patients with psychiatric or cognitive conditions that prohibit informed consent or compliance with study procedures as determined by a hematologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Rochester
Rochester, New York, United States, 14642
Actively Recruiting
Research Team
R
Rachel Rodenbach, MD, MS
CONTACT
B
Becky Gravenstede, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here